IDA Business & Technology Park, Parkmore West, Galway . Ireland
+ 353 87 434 3893
| Venter Pharma
development of efficient products for GI pathologies
Sells a kit for the diagnosis of
. LacTEST® is administered to the patient, and the lab uses Xylossay® kit for the quantification of the intolerance to lactose.
Other tests require the patients to take an “overdose” of Lactose which creates discomfort for days. LacTest uses an equivalent substance which is inert to the
body and gives more accurate results with no side effects Standard laboratory equipment and procedures required to use the kits.
Lactose intolerance affects around 38% of people of white descent and 75% of Asian, North and South American native populations and sub-Saharan ancestry, to a global of 65% of the world population. Three Million tests are currently performed in EU, USA and Russia per year.
US patents granted
Tested in humans?
clinical validation done
Spain 2012; others in process
Mexico exp. 2018.
links of interest